Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
23.47
+0.99 (4.40%)
At close: Mar 10, 2026, 4:00 PM EDT
22.75
-0.72 (-3.07%)
After-hours: Mar 10, 2026, 4:55 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $252.69 million as of March 10, 2026. Its market cap has increased by 247.42% in one year.
Market Cap
252.69M
Enterprise Value
192.18M
1-Year Change
247.42%
Ranking
Category
Stock Price
$23.47
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $252.69M, a decrease of -89.92%. That is a compound annual growth rate of -32.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 242.03M | 11.56% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 895.70M |
| Personalis | 820.31M |
| Castle Biosciences | 806.31M |
| Myriad Genetics | 481.57M |
| Fulgent Genetics | 456.90M |
| Prenetics Global | 299.55M |
| Biodesix | 185.14M |
| Insight Molecular Diagnostics | 175.31M |